NEW YORK (GenomeWeb) – German molecular diagnostics firm GNA Biosolutions said today that it has closed a E6 million ($6.7 million) Series B financing round.

New investor Robert Bosch Venture Capital led the financing. Other new investors include SHS Gesellschaft für Beteiligungsmanagement GmbH, b-to-v Partners, and UnternehemerTUM-Fonds, and join existing shareholders Mey Capital Matrix, KfW, and company founders.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.